NCT00148850View on ClinicalTrials.gov

Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients

PHASE3TerminatedINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

February 28, 2003

Study Completion Date

October 31, 2004

Conditions

HIV-Associated Lipodystrophy SyndromeHIV Infections

Interventions

DRUG

Pioglitazone

Trial Locations (1)

75020

Service des Maladies Infectieuses et Tropicales, Hopital Tenon, Paris

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Takeda

INDUSTRY

lead

French National Agency for Research on AIDS and Viral Hepatitis

OTHER_GOV